Moroccan Minister of Endowments and Islamic Affairs Meets with Undersecretary of Saudi Ministry of Islamic Affairs    Saudi Ambassador to The Philippines Meets with Filipino Minister for National Commission on Muslim Filipinos    Al-Shagdali Meets Secretary-General of Red Sea Investors Association    Weather Forecast for Friday    HRH Crown Prince Crowns Winner Al-Fayhaa with the Custodian of the Two Holy Mosques' Cup 2021/2022    Jeddah Season 2022 Launches Japanese "Anime Village" with Largest Cosplay Parade    Taif Rose Festival Attracts Nearly 1 Million Visitors, Concludes with Great Success    Saudi Arabia Heads to Cannes International Film Festival to Promote Country's Flourishing Industry and Support Emerging Talent on World Stage    King, Crown Prince congratulate President Paul Biya on Cameroon's National Day    Saudi Arabia delivers humanitarian aid worth $3.2 million to Philippines    Capital Economics expects Saudi economy to grow 10% in 2022    ZATCA clarifies conditions for buying and bringing cars from abroad    Sri Lanka defaults on debt for first time in its history    Global economic growth downgraded due to spillover from Ukraine war    Saudi Arabia took important steps to enhance food security, says minister    Nations must act together to end crisis of food insecurity: UN chief    India seeks to win public trust in crisis-hit Sri Lanka    Russian soldier pleads guilty in first war crimes trial of Ukraine conflict    Three Professors Win 2022 IsDB Prize for Impactful Achievement in Islamic Economics    Saudi Arabia bags two gold medals at GCC Games    Salman bin Ibrahim to seek third term at AFC helm    US Soccer equalizes pay in milestone with women, men    Prince Khalid, Austin review Saudi-US defense ties    Hospital admissions for eating disorders soar in Britain    Saudis in Cannes: Promoting country's flourishing film industry    Saudi Stock Exchange Main Index Ends Trading Lower at 12,427.96 Points    Japan Posts Trade Deficit of 839.2 Billion Yen in April    Asian Shares Fall    Prince Faisal, Lamamra review historical ties; discuss enhancing joint cooperation    Saudi Tourism Authority Signs Over 90 Agreements and MoU in Dubai ATM 2022    President of SAFF Participates in AFC General Assembly Meeting    36 films compete for 12 awards at Saudi Film Festival    Senegalese show support to Idrissa Gueye after homophobia accusations    Saudi Athletes Achieve Great Victories in the 2nd Day of the GCC Games Tournament in Kuwait    Kay Mellor: Actress and Fat Friends creator dies aged 71    Jazan Hosts West Asian Beach Soccer Championship    Over 250 Saudi Female and Male Players to Participate in Kuwait 3rd GCC Games on Friday    Bollywood actor's tweet reignited debate over Hindi as India's national language    SFDA Advises to Wash Dates Well Before Eating    SFDA Advises Against Mixing Surplus of Iftar and Suhoor with Different Foods or Surplus from Other Days    Ministry calls on imams to avoid long supplications in Tahajjud Prayer    Nothing wrong with a Muslim celebrating birthdays, says Saudi scholar    Ranbir Kapoor and Alia Bhatt: Bollywood wishes for star couple on wedding    SFDA Warns Against Microbes Accumulation on Coffee when Stored Incorrectly    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    Council of Senior Scholars: Muslim Brothers' Group Don't Represent Method of Islam, rather only Follows its Partisan Objectives, Violating our Graceful Religion    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Pfizer says COVID-19 vaccine protection lasts at least 6 months
Published in The Saudi Gazette on 01 - 04 - 2021

The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the manufacturer said on Thursday.
It's the first look at how long protection for a coronavirus vaccine lasts, and while six months is a modest target, it's longer than the 90 days of protection been the best estimate offered to date.
The vaccine remains more than 91 percent effective against disease with any symptoms for six months, the companies said. And it appeared to be fully effective against the worrying B.1.351 variant of the virus, which is the dominant strain circulating in South Africa and which researchers feared had evolved to evade the protection of vaccines, the companies said.
"The vaccine was 100 percent effective against severe disease as defined by the US Centers for Disease Control and Prevention (CDC), and 95.3 percent effective against severe COVID-19 as defined by the US Food and Drug Administration (FDA)," Pfizer and BioNTech said in a joint statement.
On Wednesday, the companies said a small trial of volunteers aged12 to 15 showed 100 percent efficacy in that age group.
"These data confirm the favorable efficacy and safety profile of our vaccine and position us to submit a Biologics License Application to the US FDA," Albert Bourla, Pfizer's chairman and chief executive officer, said in a statement. A BLA is an application for full approval. The vaccine currently has emergency use authorization, EUA, which falls short of full approval.
"The high vaccine efficacy observed through up to six months following a second dose and against the variant prevalent in South Africa provides further confidence in our vaccine's overall effectiveness."
The company has been studying the vaccine in more than 46,000 volunteers and has noted 927 cases of confirmed COVID-19.
"From the 927 confirmed symptomatic cases of COVID-19 in the trial, 850 cases of COVID-19 were in the placebo group and 77 cases were in the BNT162b2 group, corresponding to vaccine efficacy of 91.3 percent," it said.
"Thirty-two cases of severe disease, as defined by the CDC, were observed in the placebo group versus none in the BNT162b2 vaccinated group, indicating that the vaccine was 100 percent efficacious in this analysis against severe disease by the CDC definition. Twenty-one cases, as defined by the FDA, were observed in the placebo group versus one case in the BNT162b2 vaccinated group, indicating 95.3 percent efficacy by the FDA definition."
These definitions matter. The FDA's definition of severe disease included a raised respiratory rate indicating respiratory distress; raised heart rate, an oxygen saturation level of 93 percent or lower; respiratory failure severe enough to need additional oxygen or ventilation; a blood pressure drop indicating shock; significant kidney, liver or neurological dysfunction, admission to an intensive care unit or death.
CDC's definition includes a blood oxygen level of 94 percent or lower and an x-ray finding of lung infiltrates — an indication of pneumonia — of greater than 50 percent.
The most common adverse events were pain at the injection site, fatigue, and headache.
"In South Africa, where the B.1.351 lineage is prevalent and 800 participants were enrolled, nine cases of COVID-19 were observed, all in the placebo group, indicating vaccine efficacy of 100%," the company said.
"Vaccine safety has now been evaluated in more than 44,000 participants aged 16 years and older with more than 12,000 vaccinated participants having at least six months of follow-up after their second dose."


Clic here to read the story from its source.